The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of Gentiva Health Services Inc. (NASDAQ: GTIV) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Gentiva to maximize shareholder value before agreeing to be acquired by Kindred Healthcare Inc. (NYSE: KND).

If you would like to join the action, go to or contact Phillip Kim or Kevin Chan, toll-free at 866-767-3653, or via e-mail at or There is no cost or obligation to you.

Under the terms of the proposed transaction, shareholders will receive $14.50 per share in cash and $5.00 of Kindred common stock – equating to 0.257 shares of Kindred common stock based upon an agreed upon fixed exchange ratio – for each share of Gentiva they own. The proposed transaction is valued at approximately $1.8 billion. The investigation relates to whether the proposal for $19.50 per share in a combination of cash and stock is fair to public shareholders and whether Gentiva’s Board breached its fiduciary duties in connection with the proposed sale.

If you currently own shares of Gentiva and wish to obtain additional information, please visit the website at You may also contact Phillip Kim or Kevin Chan of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at or

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.


Contact Information:

Phillip Kim, Esq.Kevin Chan, Esq.Laurence Rosen, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 34 th FloorNew York, New York 10016Tel: (212) 686-1060Toll Free: 1-866-767-3653Fax: (212) 202-3827

Copyright Business Wire 2010